Clinigen Group plc AGM Resolutions (8953W)
November 17 2017 - 11:22AM
UK Regulatory
TIDMCLIN
RNS Number : 8953W
Clinigen Group plc
17 November 2017
17 November 2017
AGM Resolutions
On 12 October 2017 Clinigen Group plc (AIM:CLIN, "Clinigen" or
"the Group") published the Notice convening the Group's 2017 Annual
General Meeting ("AGM"), which is to be held on 28 November 2017 at
10.00am. Also on 12 October 2017, this Notice, and a letter from
the Chairman, were posted to shareholders, accompanied by a copy of
the 2017 Annual Report.
Clinigen confirms that, consistent with the statement made in
the Remuneration Report contained within the 2017 Annual Report, it
is intended that at the forthcoming AGM the Group's remuneration
policy, as set out in the Remuneration Report, will be put forward,
on an advisory basis, for shareholder approval. Shareholders who
wish to vote on the Group's remuneration policy will need to attend
the AGM and vote in person.
- Ends-
Clinigen Group plc Tel: +44 (0) 1283
495 010
Shaun Chilton, Group Chief
Executive Officer
Martin Abell, Group Chief
Financial Officer
Matt Parrish, Head of Investor
Relations
Numis Securities Limited Tel: +44 (0) 20 7260
1000
Michael Meade / Freddie Barnfield
(Nominated Adviser)
James Black / Tom Ballard
(Corporate Broking)
RBC Capital Markets - Joint Tel: +44 (0) 20 7653
Broker 4000
Marcus Jackson / Elliot Thomas
/ Jack Wood
Instinctif Partners (media Tel: +44 (0) 20 7457
relations) 2020
Melanie Toyne-Sewell / Alex
Shaw / Deborah Bell Email: clinigen@instinctif.com
About Clinigen Group
Clinigen Group plc (AIM: CLIN) is a global pharmaceutical and
services company with a unique combination of businesses focused on
providing ethical access to medicines. Its mission is to deliver
the right medicine to the right patient at the right time through
three areas of global medicine supply; clinical trial, unlicensed
and licensed medicines. Clinigen acquired Quantum Pharma in
November 2017.
For more information, please visit www.clinigengroup.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
RAGFFSFWWFWSEEF
(END) Dow Jones Newswires
November 17, 2017 12:22 ET (17:22 GMT)
Clinigen (LSE:CLIN)
Historical Stock Chart
From Apr 2024 to May 2024
Clinigen (LSE:CLIN)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Clinigen Group Plc (London Stock Exchange): 0 recent articles
More Clinigen Group News Articles